EGFR and hepatocellular carcinoma: Moreover, functional experiments have validated that the overexpression of NT5DC2 can impede EGFR ubiquitination, leading to the promotion of HCC cell proliferation and cloning in vitro, as well as the stimulation of tumor growth in vivo.